C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/14 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61P 35/00 (2006.01) C07D 217/16 (2006.01) C07D 233/16 (2006.01) C07D 401/04 (2006.01)
Patent
CA 2555745
Compounds of the formula (I): where R2, R5, R6 have the meanings as given in the description, and U, V and W, respectively, may be CR2', CR4' and CR6', respectively (with the definitions of R2', R4' and R6' again as in the description), or may be N, were io synthesized. They were found to down- regulate or inhibit the expression or function of the IGF-1 receptor.
L'invention concerne des composés de formule (I): dans laquelle R2, R5, R6 ont la signification indiquée dans la description, et U, V et W, peuvent représenter respectivement CR2', CR4' et CR6', (R2', R4' et R6' étant définis dans la description), ou peuvent représenter N, lesdits composés étant synthétisés. On a découvert que ces composés régulent négativement ou inhibent l'expression ou la fonction du récepteur de l'IGF-1.
Gunzinger Jan
Leander Kurt
Analytecon S.a.
Borden Ladner Gervais Llp
LandOfFree
Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1645855